Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
Sigyn Therapeutics (OTCQB: SIGY) will present at LD Micro Main Event XIX on Tuesday, October 21, 2025 at 4:00 PM PT at the Hotel del Coronado in San Diego.
Jim Joyce, CEO and inventor, will deliver the company presentation. The three-day conference runs October 19–21, 2025, features about 120 companies presenting in half-hour slots, and includes one-on-one investor meetings and a closing reception.
Investors can attend in person or register to watch the virtual presentation.
Sigyn Therapeutics (OTCQB: SIGY) si presenterà a LD Micro Main Event XIX il martedì 21 ottobre 2025 alle ore 16:00 PT presso l'Hotel del Coronado a San Diego.
Jim Joyce, CEO e inventore, terrà la presentazione aziendale. La conferenza di tre giorni si svolge dal 19 al 21 ottobre 2025, vede circa 120 aziende presentarsi in slot di mezz'ora e comprende riunioni one-to-one con gli investitori e una reception di chiusura.
Gli investitori possono partecipare di persona o registrarsi per seguire la presentazione virtuale.
Sigyn Therapeutics (OTCQB: SIGY) se presentará en LD Micro Main Event XIX el martes 21 de octubre de 2025 a las 4:00 PM PT en el Hotel del Coronado en San Diego.
Jim Joyce, CEO e inventor, realizará la presentación de la empresa. La conferencia de tres días se celebra del 19 al 21 de octubre de 2025, con alrededor de 120 empresas presentándose en horarios de media hora, y incluye reuniones individuales con inversionistas y una recepción de clausura.
Los inversionistas pueden asistir en persona o registrarse para ver la presentación virtual.
Sigyn Therapeutics (OTCQB: SIGY)는 LD Micro Main Event XIX에서 2025년 10월 21일 화요일 오후 4시 PT에 샌디에이고의 Hotel del Coronado에서 발표합니다.
회장 겸 발명가인 Jim Joyce가 회사 발표를 진행합니다. 3일간의 컨퍼런스는 2025년 10월 19–21일에 걸쳐 약 120개 기업이 30분 간의 발표 슬롯을 가지며 1대1 투자자 미팅과 폐막 리셉션이 포함됩니다.
투자자들은 현장 참석하거나 가상 발표를 시청하기 위해 등록할 수 있습니다.
Sigyn Therapeutics (OTCQB: SIGY) présentera lors du LD Micro Main Event XIX le mardi 21 octobre 2025 à 16h00 PT à l'hôtel del Coronado à San Diego.
Jim Joyce, PDG et inventeur, fera la présentation de l'entreprise. La conférence de trois jours se déroule du 19 au 21 octobre 2025, avec environ 120 entreprises présentant des sessions de trente minutes, et comprend des rendez-vous investisseurs en tête-à-tête et une réception de clôture.
Les investisseurs peuvent assister sur place ou s'inscrire pour regarder la présentation virtuelle.
Sigyn Therapeutics (OTCQB: SIGY) wird sich beim LD Micro Main Event XIX am Dienstag, dem 21. Oktober 2025 um 16:00 Uhr PT im Hotel del Coronado in San Diego vorstellen.
Jim Joyce, CEO und Erfinder, wird die Unternehmenspräsentation halten. Die dreitägige Konferenz läuft vom 19. bis 21. Oktober 2025, es werden etwa 120 Unternehmen in 30-Minuten-Slots präsentiert, und sie beinhaltet One-on-One-Investorengespräche sowie einen Abschlussempfang.
Investoren können persönlich teilnehmen oder sich registrieren, um die virtuelle Präsentation zu sehen.
Sigyn Therapeutics (OTCQB: SIGY) ستقدم في LD Micro Main Event XIX في الثلاثاء 21 أكتوبر 2025 الساعة 4:00 مساءً بتوقيت المحيط الهادئ في فندق ديل كورونادو في سان دييغو.
سيقدم جيم جويس، الرئيس التنفيذي والمخترع، عرض الشركة. المؤتمر الذي يستمر ثلاثة أيام يقام من 19 إلى 21 أكتوبر 2025 ويتضمن حوالي 120 شركة تقدم عروضها في فترات نصف ساعة، ويشمل اجتماعات استثمارية ثنائية واجتماع الختام وتقابلاً.
يمكن للمستثمرين الحضور شخصيًا أو التسجيل لمشاهدة العرض الافتراضي.
Sigyn Therapeutics (OTCQB: SIGY) 将在 LD Micro Main Event XIX 于 2025年10月21日星期二太平洋夏令时下午4:00 在圣地亚哥的 Coronado 酒店进行公司介绍。
CEO兼发明人 Jim Joyce 将进行公司介绍。为期三天的会议将于 2025年10月19–21日 举行，约 120家公司 以半小时的时段进行陈述，并包括一对一投资者会面和闭幕招待会。
投资者可以现场参与或注册观看虚拟演示。
- None.
- None.
Presentation on Tuesday, October 21st at 4:00 PM PT
San Diego, California--(Newsfile Corp. - October 21, 2025) - Sigyn Therapeutics, Inc. (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, announced today that it will be presenting at the 19th annual Main Event on Tuesday, October 21st at 4:00 PM PT at the Hotel del Coronado in San Diego, California. Jim Joyce, CEO and Inventor will be giving the presentation.
"The Main Event is a culmination of over 25 years of hard work and passion for small company investing. There is no organization on planet Earth that cares more about small companies succeeding than LD. To be able to connect with our community in one of the most beautiful settings imaginable brings me considerable joy. We look forward to welcoming all of our patrons and ensuring that they have a wonderful time," stated Chris Lahiji, Founder of LD Micro.
Event: LD Micro Main Event XIX
Date: Tuesday, October 21st
Time: 4:00 PM
Register to watch the virtual presentation here.
Summary of LD Micro Main Event XIX
The 2025 LD Micro Main Event XIX will run from October 19th to the 21st at the Hotel del Coronado in San Diego, California.
The first day will consist of registration, keynote speakers, and some gorgeous views of the Pacific. It will be followed by two full days of company presentations and one-on-one investor meetings concluded with a closing reception.
This three-day event will feature around 120 companies, presenting in half-hour increments, and attending private meetings with investors.
About Sigyn Therapeutics, Inc.
Sigyn Therapeutics is developing dialysis-like therapies to address cardiovascular disease and cancer. Sigyn CardioDialysis™ is a first-in-class blood purification technology being advanced to treat cardiovascular disease, the leading cause of global deaths. CardioDialysis™ is designed to reduce the circulating presence of inflammatory molecules that drive cardiovascular disease progression while simultaneously targeting cholesterol transporting lipoproteins that contribute to heart attacks, strokes, and other major adverse cardiovascular events (MACE). The Company’s development pipeline includes ImmunePrep™ to optimize the delivery of immunotherapeutic antibodies; ChemoPrep™ to enhance the targeted delivery of chemotherapy; and ChemoPure™ to reduce chemotherapy toxicity. To learn more about Sigyn Therapeutics, visit: www.SigynTherapeutics.com
About LD Micro
LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro’s mission is to provide unparalleled access and insight for those seeking the next generation of great companies.
To learn more about LD Micro, visit:
http://www.ldmicro.com
To learn more about Freedom US Markets LLC, visit:
https://www.freedomcapmkts.com/
To present or register, please contact registration@ldmicro.com.
For further information on Sigyn Therapeutics, Inc.:
Sigyn Therapeutics, Inc.
Jim Joyce
619-368-2000
jj@sigyntherapeutics.com
www.sigyntherapeutics.com
FAQ
When will Sigyn Therapeutics (SIGY) present at LD Micro Main Event XIX?
Who will present for Sigyn Therapeutics (SIGY) at the October 21, 2025 event?
How long does LD Micro Main Event XIX run and how many companies will present?
Can investors watch the Sigyn Therapeutics (SIGY) presentation virtually on October 21, 2025?
Where is LD Micro Main Event XIX taking place for the October 2025 presentations?
